Travassos, et al.25 (2018), in their review study, demonstrated that high serum levels of SCCA as a biomarker were correlated with an advanced TNM (tumor, nodes, metastases) stage of head and neck SCC, being higher in stage III and IV than in stage I and II. The gene discussed is SERPINB3; the disease is neoplasm.